Camrelizumab

Catalog No.A2016 Synonyms: SHR-1210

For research use only. Not for use in humans.

Camrelizumab is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1 with immune checkpoint inhibitory and antineoplastic activities.

Size Price Stock Quantity  
USD 707 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Quality Control

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Camrelizumab is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1 with immune checkpoint inhibitory and antineoplastic activities.
Targets
PD-1 [1]
()

Protocol

Product Details

Formulation PBS buffer, pH 7.2
Isotype Human IgG4
Source CHO cells
Storage Store at -80°C and avoid freeze-thaw cycles.

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03557411 Recruiting Non-Small-Cell Lung Cancer Shandong Cancer Hospital and Institute|Jiangsu HengRui Medicine Co. Ltd. July 9 2018 Phase 2
NCT03155425 Recruiting Hodgkin Lymphoma Adult Jiangsu HengRui Medicine Co. Ltd. June 9 2017 Phase 2
NCT03085069 Recruiting Lung Neoplasms|Carcinoma Non-Small-Cell Lung|Respiratory Tract Neoplasms Nec|Lung Disease|Respiratory Tract Disease|Neoplasm Bronchial|Carcinoma Bronchogenic Jiangsu HengRui Medicine Co. Ltd. June 9 2017 Phase 2
NCT03463876 Recruiting Hepatocellular Carcinoma Jiangsu HengRui Medicine Co. Ltd. February 5 2018 Phase 2
NCT03417895 Not yet recruiting Small-cell Lung Cancer Jiangsu HengRui Medicine Co. Ltd. February 5 2018 Phase 2
NCT03603756 Recruiting Esophageal Squamous Cell Carcinoma Chinese Academy of Medical Sciences July 31 2018 Phase 2

Tech Support

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Camrelizumab | Camrelizumab supplier | purchase Camrelizumab | Camrelizumab cost | Camrelizumab manufacturer | order Camrelizumab | Camrelizumab distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID